Vivek Subbiah: Honoring the spirit of hard work and perseverance this Labor Day 2024

Vivek Subbiah shared on LinkedIn:

“Honoring the spirit of hard work and perseverance this Labor Day 2024 !
Today, we recognize the strength and resilience of every worker who helps build our future. Happy Labor Day!
Enjoy your day of relaxation and celebration!”

Source: Vivek Subbiah/LinkedIn

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.